Schedule iii

By

May 30, 2026

Marijuana Rescheduling Reshapes Medical Research, Drug Development, and Clinical Use

The DEA and DOJ have moved FDA-approved and state-regulated medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act - a federal policy shift decades in the

• marijuana rescheduling

By

May 11, 2026

Federal Rescheduling Signals Policy Shift, But Cannabis Operators Still Face a Patchwork Reality

The Trump administration's move to reschedule marijuana to Schedule III under federal law has generated real momentum in statehouses and real confusion on the ground - sometimes simultaneously. Even

• Cannabis Rescheduling

By

Apr 28, 2026

Federal Marijuana Rescheduling Blindsides Maryland's Cannabis Industry and Regulators

Acting U.S. Attorney General Todd Blanche signed an order Thursday reclassifying medical marijuana from Schedule I to Schedule III under the Controlled Substances Act - a shift that moves it out of

• Federal Marijuana Rescheduling

By

Mar 27, 2026

Trump Signs Executive Order Rescheduling Cannabis to Schedule III

President Trump signed an executive order on Thursday directing the U.S. Drug Enforcement Administration to reclassify cannabis from Schedule I—a category for highly addictive drugs with no medical

• Trump